Actively Recruiting
Effects of Energy Drinks on Cardiovascular Endpoints
Led by University of the Pacific · Updated on 2025-11-26
3
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
CONDITIONS
Official Title
Effects of Energy Drinks on Cardiovascular Endpoints
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy male or female adults 18-40 years of age
- Female participants of child-bearing potential must have a negative pregnancy test at baseline
- Willingness to avoid caffeine and alcohol for 72 hours before study days
- Able to consume up to 1 liter of fluid within 30 minutes per visit
- Able to swallow a single large capsule per visit
- Willing to fast for 10 hours before study days (only water allowed during fasting and study period)
- Must have active health insurance throughout the study duration
You will not qualify if you...
- Corrected QT interval greater than 450 ms for males or greater than 470 ms for females at baseline
- Known medical conditions such as dyslipidemia, thyroid disease, diabetes, recurrent headache, psychiatric or neurological disorders, alcohol or drug abuse, renal or hepatic dysfunction, or electrolyte imbalances requiring hospitalization
- Known heart or cardiac diseases including atrial fibrillation, stroke, heart attack, hypertension, heart failure, vascular disease, long QT syndrome, coronary artery disease, cardiomyopathy, valvular heart disease, ventricular arrhythmia, congenital heart defect, pericardial disease, or myocarditis
- Study physician recommendation against enrollment
- Underweight (BMI <18.5) or poor nutritional status posing risk from fasting
- Contraindications to moxifloxacin, including myasthenia gravis, QT prolongation, or allergies to fluoroquinolones
- Risk factors for tendinitis, tendon rupture, peripheral neuropathy, or central nervous system side effects
- Daily use of any medication including herbal supplements (more than 2 days per week)
- Allergy to taurine
- Allergy to nuts such as peanuts, pecans, or cashews
- Allergy to adhesive pads used in monitoring devices
- Fear of needle puncture
- Current or recent (past month) use of cigarettes, vaporized nicotine, or marijuana
- Current use of any nicotine or tobacco products in any form
- Pregnant or breastfeeding women
- Positive pregnancy test at baseline
- Enrollment in another clinical study or participation in one within the last 30 days
- Non-English speaking or reading
- Failure to sign the informed consent document
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of the Pacific
Stockton, California, United States, 95211
Actively Recruiting
Research Team
Q
Quy Phan, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here